These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36790532)

  • 1. Simultaneous targeting of mitochondrial Kv1.3 and lysosomal acid sphingomyelinase amplifies killing of pancreatic ductal adenocarcinoma cells in vitro and in vivo.
    Patel SH; Bachmann M; Kadow S; Wilson GC; Abdel-Salam MML; Xu K; Keitsch S; Soddemann M; Wilker B; Becker KA; Carpinteiro A; Ahmad SA; Szabo I; Gulbins E
    J Mol Med (Berl); 2023 Mar; 101(3):295-310. PubMed ID: 36790532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine is involved in PAPTP-induced death of pancreas cancer cells by interfering with mitochondrial functions.
    Patel SH; Wilson GC; Wu Y; Keitsch S; Wilker B; Mattarei A; Ahmad SA; Szabo I; Gulbins E
    J Mol Med (Berl); 2024 Jul; 102(7):947-959. PubMed ID: 38780771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acid sphingomyelinase expression is associated with survival in resectable pancreatic ductal adenocarcinoma.
    Wilson GC; Patel SH; Wang J; Xu K; Turner KM; Becker KA; Carpinteiro A; Szabo I; Ahmad SA; Gulbins E
    J Mol Med (Berl); 2023 Jul; 101(7):891-903. PubMed ID: 37246980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of a Mitochondrial Potassium Channel in Combination with Gemcitabine and Abraxane Drastically Reduces Pancreatic Ductal Adenocarcinoma in an Immunocompetent Orthotopic Murine Model.
    Li W; Wilson GC; Bachmann M; Wang J; Mattarei A; Paradisi C; Edwards MJ; Szabo I; Gulbins E; Ahmad SA; Patel SH
    Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosome‑targeted drug combination induces multiple organelle dysfunctions and non‑canonical death in pancreatic cancer cells.
    Suzuki S; Ogawa M; Miyazaki M; Ota K; Kazama H; Hirota A; Takano N; Hiramoto M; Miyazawa K
    Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34958115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
    Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
    J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion.
    Elliott IA; Dann AM; Xu S; Kim SS; Abt ER; Kim W; Poddar S; Moore A; Zhou L; Williams JL; Capri JR; Ghukasyan R; Matsumura C; Tucker DA; Armstrong WR; Cabebe AE; Wu N; Li L; Le TM; Radu CG; Donahue TR
    Proc Natl Acad Sci U S A; 2019 Apr; 116(14):6842-6847. PubMed ID: 30894490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of lysosomal acid β-glucosidase induces cell apoptosis via impairing mitochondrial clearance in pancreatic cancer.
    Yanagaki M; Shirai Y; Shimada Y; Hamura R; Taniai T; Horiuchi T; Takada N; Haruki K; Furukawa K; Uwagawa T; Kobayashi H; Ikegami T
    Carcinogenesis; 2022 Oct; 43(9):826-837. PubMed ID: 35781559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porcupine Inhibition Disrupts Mitochondrial Function and Homeostasis in WNT Ligand-Addicted Pancreatic Cancer.
    Aguilera KY; Le T; Riahi R; Lay AR; Hinz S; Saadat EA; Vashisht AA; Wohlschlegel J; Donahue TR; Radu CG; Dawson DW
    Mol Cancer Ther; 2022 Jun; 21(6):936-947. PubMed ID: 35313331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced mitochondrial glutamine anaplerosis suppresses pancreatic cancer growth through autophagy inhibition.
    Jeong SM; Hwang S; Park K; Yang S; Seong RH
    Sci Rep; 2016 Aug; 6():30767. PubMed ID: 27477484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation.
    Nolan-Stevaux O; Lau J; Truitt ML; Chu GC; Hebrok M; Fernández-Zapico ME; Hanahan D
    Genes Dev; 2009 Jan; 23(1):24-36. PubMed ID: 19136624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth.
    Zhou C; Sun H; Zheng C; Gao J; Fu Q; Hu N; Shao X; Zhou Y; Xiong J; Nie K; Zhou H; Shen L; Fang H; Lyu J
    Cell Death Dis; 2018 Feb; 9(2):161. PubMed ID: 29415987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCAT2-mediated BCAA catabolism is critical for development of pancreatic ductal adenocarcinoma.
    Li JT; Yin M; Wang D; Wang J; Lei MZ; Zhang Y; Liu Y; Zhang L; Zou SW; Hu LP; Zhang ZG; Wang YP; Wen WY; Lu HJ; Chen ZJ; Su D; Lei QY
    Nat Cell Biol; 2020 Feb; 22(2):167-174. PubMed ID: 32029896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HSP70-mediated mitochondrial dynamics and autophagy represent a novel vulnerability in pancreatic cancer.
    Ferretti GDS; Quaas CE; Bertolini I; Zuccotti A; Saatci O; Kashatus JA; Sharmin S; Lu DY; Poli ANR; Quesnelle AF; Rodriguez-Blanco J; de Cubas AA; Hobbs GA; Liu Q; O'Bryan JP; Salvino JM; Kashatus DF; Sahin O; Barnoud T
    Cell Death Differ; 2024 Jul; 31(7):881-896. PubMed ID: 38802657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TM4SF18 is aberrantly expressed in pancreatic cancer and regulates cell growth.
    Singhal M; Khatibeghdami M; Principe DR; Mancinelli GE; Schachtschneider KM; Schook LB; Grippo PJ; Grimaldo SR
    PLoS One; 2019; 14(3):e0211711. PubMed ID: 30897168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function.
    Viale A; Pettazzoni P; Lyssiotis CA; Ying H; Sánchez N; Marchesini M; Carugo A; Green T; Seth S; Giuliani V; Kost-Alimova M; Muller F; Colla S; Nezi L; Genovese G; Deem AK; Kapoor A; Yao W; Brunetto E; Kang Y; Yuan M; Asara JM; Wang YA; Heffernan TP; Kimmelman AC; Wang H; Fleming JB; Cantley LC; DePinho RA; Draetta GF
    Nature; 2014 Oct; 514(7524):628-32. PubMed ID: 25119024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer.
    Humpton TJ; Alagesan B; DeNicola GM; Lu D; Yordanov GN; Leonhardt CS; Yao MA; Alagesan P; Zaatari MN; Park Y; Skepper JN; Macleod KF; Perez-Mancera PA; Murphy MP; Evan GI; Vousden KH; Tuveson DA
    Cancer Discov; 2019 Sep; 9(9):1268-1287. PubMed ID: 31263025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness.
    Rademaker G; Hennequière V; Brohée L; Nokin MJ; Lovinfosse P; Durieux F; Gofflot S; Bellier J; Costanza B; Herfs M; Peiffer R; Bettendorff L; Deroanne C; Thiry M; Delvenne P; Hustinx R; Bellahcène A; Castronovo V; Peulen O
    Oncogene; 2018 Aug; 37(32):4398-4412. PubMed ID: 29720728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells.
    Kumar S; Inigo JR; Kumar R; Chaudhary AK; O'Malley J; Balachandar S; Wang J; Attwood K; Yadav N; Hochwald S; Wang X; Chandra D
    Cancer Lett; 2018 Jan; 413():82-93. PubMed ID: 29107110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.